Members of the Return of Individual Results MRCT Center Workgroup (2017) and subsequent Taskforce (2021) contributed to concepts and content presented on this website, and participated in its review.
The MRCT Center would like to express thanks to all current and past workgroup/taskforce members for their commitment and contributions towards this work.
This website represents a consensus viewpoint, and does not necessarily represent the point of view of any individual member organization. Further, the individuals served in their individual capacity not as a representative of the affiliated organization or entity.
Taskforce (2021)
| Name | Affiliation |
|---|---|
| Sylvia Baedorf Kassis | MRCT Center |
| Barbara E. Bierer | MRCT Center / Brigham and Women’s Hospital / Harvard Medical |
| Linda Coleman | Yale University |
| Anna Kang Liu | Genentech / Roche |
| David Leventhal | Pfizer |
| Nancy Levitan Poorvu | Patient Advocate |
| Megan McBride | Janssen |
| Lisa Murray | MRCT Center |
| Sandra Prucka | Indiana University |
| Kate Robins | Patient Advocate |
| Jessica Scott | Takeda |
| Jamie Tyrone | Patient Advocate |
| Carol Weil | National Cancer Institute |
| Sarah White | MRCT Center |
Many thanks to those who reviewed these updated resources: Jim Armbrust, Paddy Cullinan
Workgroup (2017)
| Name | Affiliation |
|---|---|
| Carmen Aldinger | MRCT Center |
| Mary Ellen Allen | Genentech / Roche |
| Mark Barnes | MRCT Center/Ropes & Gray/Yale Law School |
| Karina Bienfait | Merck |
| Barbara Bierer | MRCT Center / Brigham and Women’s Hospital/ Harvard Medical |
| Juan Carmona | MRCT Center |
| Poorvi Chablani | Biogen |
| Karla Childers | Johnson & Johnson |
| Cathryn Clary | Novartis |
| Linda Coleman | Quorum Review IRB |
| Deborah Collyar | Patient Advocates In Research (PAIR) |
| Kelly Coulbourne | AstraZeneca |
| Patrick Cullinan | Takeda Pharmaceuticals |
| Roberta Driscoll | Dana-Farber Cancer Institute |
| Ricardo Eccard da Silva | Brazilian Health Surveillance Agency – Anvisa |
| Arianna Franca | Johns Hopkins University |
| Elizabeth Frank | Dana Farber/Harvard Cancer Center |
| Zachary Hallinan | Clinical Trials Transformation Initiative |
| Lea Harty | Pfizer |
| Nicole Hinton | Biogen |
| Tab (Tabassum) Hoda | Amgen |
| Jaime Houde | EMD Serono |
| Cheryl Jernigan | Susan G. Komen |
| Michael Johnson | MRCT Center |
| Scott Kennedy | Novartis |
| Youngshin Kim | Beijing United Family Hospital and Clinics |
| Barbara Kress | Merck |
| Sarah Larson | Biogen |
| David Leventhal | Pfizer |
| Rebecca Li | MRCT Center/ Brigham and Women’s Hospital/ Harvard Medical School |
| Dylan Marashi | MRCT Center Intern |
| Gloria Mason | Harvard Medical School |
| Debra Mathews (Co-Chair) | Johns Hopkins Berman Institute of Bioethics |
| Megan McBride | Janssen/Johnson & Johnson |
| Jules Mitchel | Target Health Inc. |
| Thomas Morgan | Novartis |
| Dana Leff Niedzielska | August Research |
| P. Pearl O'Rourke | Partners HealthCare |
| Jane Perlmutter | Gemini Group |
| Usharani Pingali | Nizam's Institute of Medical Sciences, India |
| Wasana Prasitsuebsai | GlaxoSmithKline; formerly: HIV-NAT, the Thai Red Cross AIDS Research Centre, Thailand |
| Sandy Prucka (Co-Chair) | Eli Lilly and Company |
| David Pulford (Co-Chair) | GlaxoSmithKline, United Kingdom |
| Stephen Rosenfeld | Quorum Review IRB |
| Jessica Scott | GlaxoSmithKline |
| Jina Shah | Genentech / Roche |
| Lana Skirboll | Sanofi |
| Lynn Sleeper | Boston Children's Hospital/Harvard Medical School |
| Adrian Thorogood | Global Alliance for Genomics and Health |
| Carol Weil | National Cancer Institute, USA |
| Crispin Woolston | Sanofi |
| Sheila Young | GlaxoSmithKline |